EE Impact

Alcon

Switzerland · Pharma & Healthcare

LeaveRussia detail: Pausing Investments

Operations suspended

Alcon is an American Swiss medical company specializing in eye care products with headquarters in Geneva, Switzerland.

Status last verified 03/08/2026Source checked 05/05/2022Company website ↗LeaveRussia profile ↗

Business in Russia

The company has a representative office in Russia.

Decision trail

Decision date 25/04/2022 · Reference ↗

Alcon suspended all capital investments in Russia and have halted enrollment in clinical research there.

Local stats (LeaveRussia)

Assets(RF), mln.USD
111
Capital(RF), mln.USD
37
Glob.Revenue, mln.USD
8291
Revenue(RF), mln.USD
172
Staff(RF), 2021
278
Taxes(RF), mln.USD
7

Status history since 2022

  1. 03/08/2026 suspended · Imported from KSE LeaveRussia

Possible sanctions matches

Name-based matches against EU/US/UK lists — verify identity before drawing conclusions.

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.